Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingolf Cascorbi

Showing results (61-70 of 192) with videos related to

Pageof 20
Sort By:
Basic & Clinical Pharmacology & Toxicology|October 12, 2007
Educating European (junior) doctors for safe prescribingSimon R J Maxwell, Ingolf Cascorbi, Michael Orme, et al.
Pharmacogenomics|April 21, 2012
Highlights from the latest articles in breast cancer pharmacogenomicsJonathan Krell, Adam E Frampton, Ingolf Cascorbi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 6, 2006
Multidrug resistance 1 genotype and disposition of budesonide in early primary biliary cirrhosisKarin Dilger, Ingolf Cascorbi, Frank Grünhage, et al.
Molecular and Cellular Neurosciences|April 18, 2017
Crosstalk control and limits of physiological c-Jun N-terminal kinase activity for cell viability and neurite stability in differentiated PC12 cellsVicki Waetzig, Milana Belzer, Wiebke Haeusgen, et al.
Anticancer Research|September 30, 2024
Enhancing Retinoic Acid-mediated Effects Through Inhibition of CYP26A1, CYP26B1 and HGF Signaling in Neuroblastoma CellsReema Sami Issa, Meike Kaehler, Nina Sophie Pommert, et al.
Pharmacogenomics|February 20, 2016
Length variants of the ABCB1 3'-UTR and loss of miRNA binding sites: possible consequences in regulation and pharmacotherapy resistanceOliver Bruhn, Katharina Drerup, Meike Kaehler, et al.
Pharmacogenetics and Genomics|November 8, 2005
Identification and functional analysis of genetic variants of the human beta-glucuronidase in a German population sampleMatthias Gratz, Christiane Kunert-Keil, Ulrich John, et al.
Carcinogenesis|January 1, 2003
CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formationKroum Alexandrov, Ingolf Cascorbi, Margarita Rojas, et al.
Pharmacogenetics and Genomics|March 13, 2008
Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinololSierk Haenisch, Karen May, Danilo Wegner, et al.
Pharmacogenetics and Genomics|January 14, 2012
MicroRNA profiling in K-562 cells under imatinib treatment: influence of miR-212 and miR-328 on ABCG2 expressionEleonora Turrini, Sierk Haenisch, Sandra Laechelt, et al.
Pageof 20

Showing results (61-70 of 192) with videos related to

Sort By:
Pageof 20
Basic & Clinical Pharmacology & Toxicology|October 12, 2007
Educating European (junior) doctors for safe prescribingSimon R J Maxwell, Ingolf Cascorbi, Michael Orme, et al.
Pharmacogenomics|April 21, 2012
Highlights from the latest articles in breast cancer pharmacogenomicsJonathan Krell, Adam E Frampton, Ingolf Cascorbi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 6, 2006
Multidrug resistance 1 genotype and disposition of budesonide in early primary biliary cirrhosisKarin Dilger, Ingolf Cascorbi, Frank Grünhage, et al.
Molecular and Cellular Neurosciences|April 18, 2017
Crosstalk control and limits of physiological c-Jun N-terminal kinase activity for cell viability and neurite stability in differentiated PC12 cellsVicki Waetzig, Milana Belzer, Wiebke Haeusgen, et al.
Anticancer Research|September 30, 2024
Enhancing Retinoic Acid-mediated Effects Through Inhibition of CYP26A1, CYP26B1 and HGF Signaling in Neuroblastoma CellsReema Sami Issa, Meike Kaehler, Nina Sophie Pommert, et al.
Pharmacogenomics|February 20, 2016
Length variants of the ABCB1 3'-UTR and loss of miRNA binding sites: possible consequences in regulation and pharmacotherapy resistanceOliver Bruhn, Katharina Drerup, Meike Kaehler, et al.
Pharmacogenetics and Genomics|November 8, 2005
Identification and functional analysis of genetic variants of the human beta-glucuronidase in a German population sampleMatthias Gratz, Christiane Kunert-Keil, Ulrich John, et al.
Carcinogenesis|January 1, 2003
CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formationKroum Alexandrov, Ingolf Cascorbi, Margarita Rojas, et al.
Pharmacogenetics and Genomics|March 13, 2008
Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinololSierk Haenisch, Karen May, Danilo Wegner, et al.
Pharmacogenetics and Genomics|January 14, 2012
MicroRNA profiling in K-562 cells under imatinib treatment: influence of miR-212 and miR-328 on ABCG2 expressionEleonora Turrini, Sierk Haenisch, Sandra Laechelt, et al.
Pageof 20